National Cancer Genetics MDT

The National Cancer Genetics MDT (UKCGG National CGM) is a collaboration between the CanGene-CanVar Programme and the UK Cancer Genetics Group (UKCGG), which aims to create a regular national forum to discuss complex cancer genetics cases, improve patient management and expand clinical knowledge.

For patient confidentiality and clinical governance, meeting attendees will be required to register for the meeting in advance and are required to work within the NHS in the area of cancer genetics.

National Cancer Genetics MDT Objectives:

Creation of a national multidisciplinary professional network and regular forum to discuss and advise on complex cancer genetics cases.
Improve outcomes and consistency of care for patients by facilitating multidisciplinary discussion.
Identify areas in which national guidelines are required or need updating.
Improve training and education in clinical cancer genetics.
Facilitate relevant publications in peer-reviewed journals based on cases discussed, best practice guidelines and the value of a national forum for clinicians and patients.

Next Meeting

17 December 2020

Agenda

Mixed Cases

Please see our UKCGG National CGM resources below for an up-to-date list of meeting summaries, educational tools, references and web-based links.

If you are a member of the British Society for Genetic Medicine (BSGM) and are interested in becoming part of the UKCGG, please click here for more information.

Follow this link below:

https://www.eventbrite.co.uk/e/ukcgg-national-cancer-genetics-mdt-tickets-127158914737

Please note to register you MUST be an NHS professional within cancer genetics and provide the following information:

Full name, NHS or academic email and place of work.

Registration will close on December 13th with a Teams invite being sent out following this.

How to register for the next MDT?

National Cancer Genetics MDT Format

Bi-monthly 60-75 minute MDT via Microsoft Teams (with the possibility to increase this to monthly)

Current time slot: 12:30-13:45, 3rd Thursday of the month, starting 15th October (to review future dates and alter if required)

Ground rules for the meeting will be circulated to all attendees

MDT to alternate between:

Expert topic - Short presentation by an invited expert and then discussion of 3-4 cases relevant to that specific topic
Mixed cases - Approx. 6 cases to include a mixture of cases where a clinical decision is required and "known" cases highlighting a specific learning point

Cases to be submitted in advance of the meeting using a set slide format clearly stating clinical questions or learning points

Cases which involve variant classification should be discussed in Can-VIG

Cases which involve significant ethical issues/debates should be discussed in GenETHICS

There will be nominated session Chair (Consultant in Cancer Genetics/Senior GC) which can be rotated through different centres

CPD accreditation (RCP) if possible

The Chair will select the cases for discussion and run the meeting with the help of an additional person to minute discussions and agreed actions

At least one representative from each centre should attend

Resources

UKCGG National CGM Information Last updated: 17 September 2020

An outline of the UKCGG National Cancer Genetics MDT meeting objectives and format.

Created by Helen Hanson, Anju Kulkani, Fiona Lalloo and Marc Tischkowitz.

On behalf of UKCGG Council and CanGene-CanVar.

UKCGG National CGM Attendee Ground Rules Last updated: 17 September 2020

This document summaries the attendee and presenter etiquette, along with information governance and clinical responsibility ground rules.

Created by Helen Hanson, Anju Kulkani, Fiona Lalloo and Marc Tischkowitz.

On behalf of UKCGG Council and CanGene-CanVar.

UKCGG National CGM Summary 15th October 2020 (Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome) Last updated: 15 October 2020

A summary document of the first UKCGG National Cancer Genetics MDT which took place on the15th of October 2020. Focusing on Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome.

Created by Helen Hanson, Anju Kulkani, Fiona Lalloo and Marc Tischkowitz.

On behalf of UKCGG Council and CanGene-CanVar.

UKCGG National CGM 15th October 2020 (Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome) Presentation Slides

The presentation slides from the first UKCGG National Cancer Genetics MDT which took place on the 15th of October 2020. Focusing on Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome (Patient Information Removed).

Created by Helen Hanson..

On behalf of UKCGG Council and CanGene-CanVar.

UKCGG Website

GenETHICS Website